Table 2.
Patients’ Prior Treatment History
| Prior Treatments | No. (%) of Patients (N=46)a |
|---|---|
| Prior chemotherapy | |
| Yes | 14 (30.4) |
| No | 32 (69.6) |
| Prior anthracycline | |
| Neoadjuvant | 10 (21.7) |
| Adjuvant | 30 (65.2) |
| Metastatic | 1 (2.2) |
| None | 5 (10.9) |
| Prior trastuzumab | |
| Neoadjuvant | 3 (6.5) |
| Adjuvant | 10 (21.7) |
| Metastatic | 13 (28.3) |
| None | 20 (43.5) |
| Prior taxane | |
| Neoadjuvant | 6 (13.0) |
| Adjuvant | 25 (54.3) |
| Metastatic | 9 (19.6) |
| None | 6 (13.0) |
Percentages may not total 100% due to rounding.